论文部分内容阅读
胰高血糖素样肽-1(GLP-1)类似物艾塞那肽(exenatide)是近年来在2型糖尿病治疗领域中研发出的以双激素缺陷为靶向的新型降糖药物之一。其具有降低血糖而不引起低血糖且有降低体重的作用,另有报道其具有心血管保护作用和抑制乳腺癌细胞增长作用。
The exenatide of the glucagon-like peptide-1 (GLP-1) analogue is one of the novel hypoglycemic drugs that have been developed in the treatment of type 2 diabetes in recent years to target biliary hormones. It has the effect of lowering blood glucose without causing hypoglycemia and reducing body weight. It has also been reported that it has a cardiovascular protective effect and inhibits the growth of breast cancer cells.